Philip Lee Sheridan

Title: Innovations by Philip Lee Sheridan

Introduction

Philip Lee Sheridan is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of therapeutic proteins, holding two patents that showcase his innovative approaches. His work focuses on methods for assessing and identifying conditionally active therapeutic proteins, which have the potential to revolutionize treatment options.

Latest Patents

Sheridan's latest patents include "Methods for assessing and identifying or evolving conditionally active therapeutic proteins" and "Methods for evolving or selecting or producing therapeutic proteins that exhibit reduced adverse side-effects." The first patent describes an in vitro assay designed to identify conditionally active therapeutic proteins that demonstrate improved activity in specific in vivo environments. The methodology involves testing the activity of a protein under conditions where normal or increased activity is desired, followed by testing under conditions where reduced activity is preferred. By comparing the results, Sheridan's methods allow for the selection of proteins that exhibit greater activity in desired conditions. The second patent focuses on producing a vector-producing cell line utilizing a high multiplicity of transduction, detailing the characteristics of retroviral vector particle-producing cells.

Career Highlights

Throughout his career, Sheridan has worked with notable companies such as Chiron Corporation and Halozyme, Inc. His experience in these organizations has contributed to his expertise in the development of therapeutic proteins and innovative biotechnological solutions.

Collaborations

Sheridan has collaborated with esteemed colleagues, including Mordechai Bodner and Nicholas J DePolo. These partnerships have further enhanced his research and development efforts in the field of therapeutic proteins.

Conclusion

Philip Lee Sheridan's innovative work in the realm of therapeutic proteins demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of protein functionality and the potential for improved therapeutic outcomes. Sheridan's contributions are poised to make a lasting impact in the field of biotechnology.